Jay Hoying, PHD

Chief Scientist
ASI Life Sciences

James (Jay) Hoying is a Partner and Chief Scientist at Advanced Solutions Life Sciences (ASLS) with more than 30 years of experience in basic and applied health sciences with a focus on tissue biology, tissue vascularization, and tissue fabrication. Prior to joining ASLS, he was Professor and Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) where he developed a broad background in cell and tissue therapeutics and translated innovations to industry and the clinic. At ASLS, he also directs an active Applications Laboratory developing vascularized human tissue models, tissue therapeutics, and manufacturing protocols. He and his team work with a number of partners, including the Advanced Regenerative Manufacturing Institute (ARMI) and the VA Offices of Healthcare Innovation and Advanced Manufacturing (X_Labs), advancing Point-of-Care tissue manufacturing. Dr. Hoying pioneered a novel tissue vascularizing approach, holding numerous patents related to vascularizing tissues and other HCT/P-based therapies. He has published over 135 original research papers, reviews, and book chapters. Dr. Hoying currently reviews grant proposals for the National Institutes of Health, the Veterans Administration, the National Science Foundation, the American Heart Association, and funding agencies around the world. Dr. Hoying serves on advisory committees for the state of New Hampshire technology and business development efforts and participates in federal programs related to biotechnology and biomanufacturing.

Disclosure information not submitted.

Presentation(s):

• Point-of-Care Manufacturing of Tissues

  Tuesday, April 14, 2026
  11:00 AM - 11:30 AM East Coast USA Time